EQUITY RESEARCH MEMO

Koronis Biomedical Technologies

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)20/100

Koronis Biomedical Technologies (KBT) is a privately held contract research and development company founded in 2003 and based in Minneapolis, Minnesota. The firm specializes in integrating advanced electronic design, software engineering, and sensor technologies to create novel medical solutions. KBT operates primarily through providing R&D and product design services to partners in the medical device sector, rather than developing its own proprietary pipeline. While the company has a long history and expertise in medical device innovation, its business model is service-based, which limits direct visibility into its growth prospects and reduces investor appeal for those seeking high-risk, high-reward biomedical investments.

Upcoming Catalysts (preview)

  • TBDMajor contract win with large medical device manufacturer30% success
  • TBDFDA clearance for a client's device developed with KBT's technology20% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)